University of Hawaii Cancer Center

Home
United States
Honolulu, HI
University of Hawaii Cancer Center

Call Directions Website Contact the practice

The University of Hawai'i Cancer Center is saving lives in Hawai‘i and the Pacific. We are inspiring hope by working to erase health disparities and end cancer.
(1)

Of 74 NCI-designated centers in the US, we are the only one serving Hawai‘i and the Pacific.

10/14/2026

How can exercise help you during your cancer journey? Check out physical therapist Cheri Teranishi-Hashimoto's explanation of the benefits of physical activity for cancer patients, survivors and thrivers, to maintain your health and improve your quality of life.
You can learn more — and even try some gentle movement! — this Saturday, Oct. 17, at "Let's Move! The Important of Physical Activity in the Cancer Journey," a free public event hosted by the Susan C. Hirano Cancer CARE Community and ‘Ohana Pink programs of the UH Cancer Center. Try adapted hula, and stretching and strengthening activities, and learn what simple, fun exercise can do for you!

E komo mai — join us! Sign up here: https://www.eventbrite.com/e/lets-move-the-importance-of-physical-activity-in-the-cancer-journey-tickets-1996759513456

10/09/2026

TIME IS RUNNING OUT to sign up for this FREE and FUN public workshop on Oct. 17 at our University of Hawaii Cancer Center!

Deadline is this Saturday to register for "Let's Move! The Importance of Physical Activity in the Cancer Journey" (link in comments), presented by our Susan C. Hirano Cancer CARE Community and ‘Ohana Pink programs. Patients/survivors/thrivers, caregivers, family members, healthcare providers and other supporters all are welcome! You'll learn about the research pointing to the strong benefits of movement ... and you'll get to try two gentle group activities to get your body moving. Activities will be modifiable so that any level may participate. Please join us!

09/18/2026

Researchers at the University of Hawaiʻi have identified a potential method for the early detection of lung cancer, before the disease is clinically identified.

The investigators have identified a panel of 31 small non-coding RNAs (sncRNAs) in circulating plasma exosomes associated with lung cancer risk up to 10 years before clinical diagnosis. The findings suggest the potential for a blood-based approach to identify individuals at elevated risk during the preclinical period, when lung cancer may be developing but remains clinically undetected.

The study was led by corresponding author Youping Deng, PhD; first author and PhD candidate Zhuokun Feng, MD; and second author Masaki Nasu, PhD, from the Department of Quantitative Health Sciences at the UH John A. Burns School of Medicine. Deng is also a researcher in the UH Cancer Center’s Cancer Biology program as well as co-director of the UH Cancer Center’s Genomics and Bioinformatics Shared Resource. Loïc Le Marchand, MD, PhD, also of the UH Cancer Center, and the contact PI of the Multiethnic Cohort (MEC) Study, served as a co-corresponding author.

Click on the link in the comment below to read the story in our website Newsroom.

09/05/2026

Our University of Hawaii Cancer Center faculty held a full-day retreat today, to grow understanding and collaboration among our investigators and programs. Presentations by researchers on their latest work, plans and opportunities were followed by roundtable discussions. Ultimately the goal is to maximize and accelerate our scientific discoveries to ease the cancer burden, make an impact for people with cancer, and save more lives in Hawai‘i, the Pacific and beyond. We are excited about all the enthusiastic momentum built today!

09/04/2026

A groundbreaking new pancreatic cancer drug that experts predict will transform treatment for the notoriously deadly disease has been approved by the Food and Drug Administration — and it will be the focus of our next "Quest for a Cure" free public-education event, on Wednesday, Sept. 16.

Dr. Elizabeth Nakasone of our UH Cancer Center is among the researchers who have led pivotal clinical trials to help bring daraxonrasib to patients. Dr. Jared Acoba, also of the UH Cancer Center, is involved with a first-line pancreatic cancer clinical trial launching at The Queen's Medical Center, one of our center's valued partners in the Hawai‘i Cancer Consortium. Patients and caregivers touched by pancreatic cancer also will share their perspectives.

To join us for "Quest for a Cure: New Breakthroughs in Pancreatic Cancer Clinical Trials," or find more information, click on the link in comments section below.

09/03/2026

Our center's Kū Ola mobile offers clinical services such as blood pressure checks, pulse oximetry, and spirometry readings.
Mahalo to and for partnering on this initiative.
Want to see the Kū Ola mobile clinic in your neighborhood? Visit our kuola.org and let the staff know where the clinic should go next.

08/28/2026

Congratulations to the team at the Body Composition Shared Resource Laboratory at our University of Hawaii Cancer Center, which has received a prestigious designation as an International Atomic Energy Agency (IAEA) Collaborating Centre. The designation recognizes it as a center of excellence in assessing body composition, an important risk factor in cancer and other diseases. Led by Director Dr. John Shepherd, the lab is now one of only eight IAEA Collaborating Centres in human health worldwide, and of those, the only one dedicated to nutrition. The designation includes a work plan to provide training to Pacific island health workers through 2030. The full lab team was recognized in a plaque ceremony on Wednesday. Read the story on our website; link below.

08/26/2026

Major news today in the cancer research field: A groundbreaking pancreatic cancer drug that experts predict will transform treatment for the notoriously deadly disease has been approved by the Food and Drug Administration, NBC and other media report.

Dr. Elizabeth Nakasone of our UH Cancer Center is among the researchers who have led pivotal clinical trials to help bring daraxonrasib to patients. Dr. Jared Acoba, also of the UH Cancer Center, is involved with a first-line pancreatic cancer clinical trial launching at The Queen's Medical Center, one of our center's valued partners in the Hawai‘i Cancer Consortium.

If you'd like to learn more, daraxonrasib will be the focus of a free public event on Sept. 16 and the UH Cancer Center, "Quest for a Cure: New Breakthroughs in Pancreatic Cancer Clinical Trials." Drs. Nakasone and Acoba are among the featured speakers.

Link to the NBC story pictured, and link to register for the "Quest for a Cure" event, are in comments section below.

Address

701 Ilalo Street
Honolulu, HI
96813

Telephone

+18085863010

Website

http://www.uhcancercenter.org/, http://www.facebook.com/UHCancerCenter, http://www.youtube.com/UHCancerCenter, http://ww

Alerts

Be the first to know and let us send you an email when University of Hawaii Cancer Center posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to University of Hawaii Cancer Center:

IV Ocean Therapy
119 Merchant Street STE 102

Want your practice to be the top-listed clinic in Honolulu?